ArticleGerontology2026
Post-COVID-19 Condition Diagnosis among Older People: Findings from Swedish National Register Data.
Article in Gerontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPost-COVID-19 condition (PCC) denotes the persistence of symptoms following Severe Acute Respiratory Syndrome Coronavirus 2 infection. PCC poses a large disease burden worldwide. We aimed to explore the epidemiological characteristics of clinically diagnosed PCC among older people aged ≥65 years in Sweden and to establish a machine learning tool to predict PCC risk.
methodsThis nationwide register-based study employed a cross-sectional design. Prevalence of PCC diagnosis recorded in hospital and specialized outpatient care settings among older people aged ≥65 years in Sweden was calculated. Logistic regression models were employed to assess the associations between various factors and PCC diagnosed in hospital and specialized outpatient care. A prediction model based on extreme gradient boosting was constructed based on selected features.
resultsOf 236,943 older people aged ≥65 years who were diagnosed with COVID-19, 2.5% of them were diagnosed with PCC in hospital or specialized outpatient care. The odds of PCC diagnosed in hospital and specialized outpatient care in women were lower (odds ratio [OR] = 0.78, 95% confidence interval [CI]: 0.73-0.82). The odds decreased for each additional year of age (OR = 0.98, 95% CI: 0.98-0.98). Higher odds of PCC were found in people with higher Charlson Comorbidity Index and who used more types of medication. The odds of PCC were the lowest for infections during Omicron-predominant period (OR = 0.09, 95% CI: 0.08-0.10). The predicted PCC risk was generally higher among individuals aged 65-74 years with higher comorbidity burden, with more types of medication use, and during early variant-dominant periods.
conclusionIn summary, the prevalence of PCC diagnosis among older people in Sweden was relatively low when restricted to hospital and specialized outpatient care. A higher burden of comorbidities and more types of medication use were associated with increased odds of PCC diagnosed in hospital and specialized outpatient care. Register-based predictive models may help identify older people at higher risk of PCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.